Ethyl 2-(2-chlorophenyl)acetate

Catalog No. :
ACTZXD192
CAS No. :
40061-54-9
Molecular Formula :
C10H11ClO2
Molecular Weight :
198.65

IUPAC Name:ethyl 2-(2-chlorophenyl)acetate

Ethyl 2-(2-chlorophenyl)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
500g97%$114.00Login to see priceIn stockInquiry
1000g97%$202.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 2-(2-chlorophenyl)acetate
IUPAC Nameethyl 2-(2-chlorophenyl)acetate
MDL No.MFCD09264019
Molecular FormulaC10H11ClO2
Molecular Weight198.65
SMILESCCOC(=O)CC1=C(Cl)C=CC=C1
InChI KeyMUANZYIPCHDGJH-UHFFFAOYSA-N
SynonymEthyl 2-(2-chlorophenyl)acetate | 40061-54-9 | (2-CHLOROPHENYL)ACETIC ACID ETHYL ESTER | MFCD09264019 | ETHYL 2-CHLOROPHENYLACETATE | Benzeneacetic acid, 2-chloro-, ethyl ester | Ethyl2-(2-chlorophenyl)acetate | Dodecanedioyldichloride | ethyl o-chlorophenylacetate | SCHEM
CAS No.40061-54-9
PubChem CID10081468

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACTZXD192 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. ACLYBU038 route compound structure diagram
    ACLYBU0382444-36-2 In Stock
  4. Then
  5. ACTZXD192 route product structure diagram
    ACTZXD19240061-54-9 In Stock
Inquiry

2. ACTZXD192 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. ACLYBU038 route compound structure diagram
    ACLYBU0382444-36-2 In Stock
  4. Plus
  5. ACBFSC511 route compound structure diagram
    ACBFSC51143086-58-4
  6. Then
  7. ACTZXD192 route product structure diagram
    ACTZXD19240061-54-9 In Stock
Inquiry

Comments (0)